Horowitz, R
In the PIONEER-4 trial, 11% of the patients using oral semaglutide discontinued treatment because of adverse effects compared to 9% of the patients using subcutaneous liraglutide (Pratley et al., 2019)
The Science Behind Weight Loss Plateaus While your rate of weight loss will likely slow over time, its important to recognize that the dreaded semaglutide weight loss stall is not necessarily because of the medication losing potency, or your body developing a tolerance
Common Misconceptions About the GLP-1 Diet As GLP-1 medications have become more popular, so have misconceptions about how you should eat while taking them
Obesity itself significantly impairs male reproductive function through hormonal disruption, reduced sperm quality, and metabolic dysfunction
But the risks associated with self-administering unregulated, research-grade peptides are real and should not be underestimated